| HPTN 035 DAIDS SOP for Source Documentation | 2002-Aug-01 | 858.8 KB |
| HPTN 035 DAIDS SOP for Essential Documents | 2002-Aug-01 | 368.21 KB |
| Manual |
| HPTN 035 Overview and Version Control | 2008-Apr-18 | 26.64 KB |
| Section 01: Introduction | 2007-Jan-31 | 135.9 KB |
| Section 02: Protocol | 2007-Jan-31 | 792.86 KB |
| Section 03: Documentation Requirements | 2007-Jan-31 | 189.37 KB |
| Section 04: Participant Accrual | 2007-Jan-31 | 400.82 KB |
| Section 05: Informed Consent | 2007-Jan-31 | 1.35 MB |
| Section 06: Participant Follow-up | 2008-Apr-18 | 298.56 KB |
| Section 07: Visit Checklists | 2008-Apr-01 | 543.02 KB |
| Section 08: Participant Retention | 2007-Jan-31 | 142.2 KB |
| Section 09: Study Product Considerations for Non-Pharmacy Staff | 2007-Jan-31 | 230.8 KB |
| Section 10: Clinical Considerations | 2007-Nov-07 | 197.97 KB |
| Section 11: Adverse Event Reporting and Safety Monitoring | 2007-Aug-01 | 400.17 KB |
| Section 12: Laboratory Considerations | 2007-Nov-07 | 99.59 KB |
| Section 13: Data Collection | 2007-Jan-31 | 1.66 MB |
| Section 14: Data Communiques | 2007-Jan-31 | 351.95 KB |
| Section 15: Study Reporting Plan | 2007-Jan-31 | 32.49 KB |
